Haemonetics Corp balance sheet
At the end of fiscal 2026, Haemonetics Corp had total assets of $2.40bn and shareholders' equity of $796m. It held $245m in cash against $1.24bn of debt: net debt of $994m.
Balance sheet
| Fiscal year | 2010Apr 2010 | 2011Apr 2011 | 2012Mar 2012 | 2013Mar 2013 | 2014Mar 2014 | 2015Mar 2015 | 2016Apr 2016 | 2017Apr 2017 | 2018Mar 2018 | 2019Mar 2019 | 2020Mar 2020 | 2021Apr 2021 | 2022Apr 2022 | 2023Apr 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 142 | 197 | 229 | 179 | 192 | 161 | 115 | 140 | 180 | 169 | 137 | 192 | 259 | 284 | 179 | 307 | 245 | 223 |
| Receivables | 119 | 127 | 135 | 170 | 165 | 146 | 157 | 153 | 151 | 185 | 165 | 128 | 159 | 179 | 207 | 203 | 217 | 216 |
| Inventory | 80 | 84 | 117 | 184 | 198 | 211 | 187 | 177 | 161 | 194 | 270 | 323 | 293 | 259 | 317 | 365 | 306 | 307 |
| Total current assets | 386 | 449 | 527 | 597 | 623 | 558 | 488 | 510 | 521 | 576 | 604 | 694 | 756 | 770 | 769 | 935 | 835 | 811 |
| Goodwill | 110 | 115 | 115 | 330 | 337 | 334 | 268 | 211 | 211 | 211 | 211 | 466 | 467 | 466 | 565 | 604 | 656 | 657 |
| Total assets | 764 | 833 | 911 | 1,462 | 1,514 | 1,485 | 1,319 | 1,239 | 1,237 | 1,275 | 1,267 | 1,820 | 1,860 | 1,935 | 2,196 | 2,451 | 2,396 | 2,365 |
| Accounts payable | 26 | 28 | 35 | 50 | 54 | 48 | 40 | 43 | 55 | 63 | 51 | 50 | 58 | 64 | 73 | 67 | 51 | 56 |
| Deferred revenue (current) | — | — | — | — | — | 22 | 27 | 26 | 26 | 27 | 29 | 26 | 27 | 30 | 31 | 43 | 42 | — |
| Total current liabilities | 135 | 109 | 131 | 180 | 217 | 189 | 186 | 211 | 385 | 236 | 275 | 253 | 442 | 252 | 300 | 578 | 283 | 263 |
| Short-term debt | 16 | 1 | 1 | 23 | 46 | 22 | 43 | 61 | 194 | 28 | 77 | 17 | 214 | 12 | 10 | 304 | 5 | 5 |
| Long-term debt | 4 | 4 | 3 | 457 | 392 | 406 | 365 | 254 | 59 | 322 | 306 | 691 | 559 | 754 | 798 | 921 | 1,220 | 1,169 |
| Total debt | 21 | 5 | 4 | 486 | 440 | 430 | 408 | 316 | 254 | 350 | 382 | 708 | 774 | 766 | 808 | 1,225 | 1,240 | 1,188 |
| Shareholders' equity | 593 | 686 | 733 | 769 | 838 | 826 | 722 | 740 | 752 | 668 | 587 | 732 | 749 | 818 | 960 | 821 | 796 | 837 |
| Net debt (negative = net cash) | −121 | −192 | −225 | 307 | 248 | 270 | 293 | 176 | 74 | 181 | 245 | 515 | 514 | 481 | 629 | 918 | 994 | 965 |
| Shares outstanding | 51m | 51m | 51m | 51m | 52m | 52m | 51m | 52m | 52m | 51m | 50m | 51m | 51m | 50m | 51m | 48m | 45m | 45m |
| Quarter | 2025 Q2Sept 2024 | 2025 Q3Dec 2024 | 2025 Q4Mar 2025 | 2026 Q1Jun 2025 | 2026 Q2Sept 2025 | 2026 Q3Dec 2025 | 2026 Q4Mar 2026 | 2027 Q1Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 214 | 212 | 203 | 201 | 207 | 196 | 217 | 216 |
| Inventory | 382 | 360 | 365 | 361 | 336 | 321 | 306 | 307 |
| Total current assets | 956 | 1,006 | 935 | 913 | 900 | 944 | 835 | 811 |
| Goodwill | 616 | 605 | 604 | 607 | 606 | 607 | 656 | 657 |
| Total assets | 2,525 | 2,531 | 2,451 | 2,462 | 2,442 | 2,491 | 2,396 | 2,365 |
| Accounts payable | 69 | 63 | 67 | 46 | 62 | 49 | 51 | 56 |
| Deferred revenue (current) | — | — | 43 | — | — | — | 42 | — |
| Total current liabilities | 274 | 253 | 578 | 531 | 548 | 540 | 283 | 263 |
| Short-term debt | 5 | 5 | 304 | 304 | 304 | 305 | 5 | 5 |
| Long-term debt | 1,220 | 1,220 | 921 | 921 | 920 | 920 | 1,220 | 1,169 |
| Total debt | 1,225 | 1,225 | 1,225 | 1,225 | 1,225 | 1,225 | 1,225 | 1,174 |
| Shareholders' equity | 879 | 907 | 821 | 882 | 849 | 911 | 796 | 837 |
| Shares outstanding | 50m | 50m | 48m | 48m | 47m | 47m | 45m | 45m |
Compare with peers
- Stevanato Group S.p.a. balance sheet
- Penumbra Inc balance sheet
- Merit Medical Systems Inc balance sheet
- Integra Lifesciences Holdings Corp balance sheet
- Tandem Diabetes Care Inc balance sheet
Head to head: HAE vs STVNHAE vs PENHAE vs MMSI
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies